*ST亚太：预计2025年全年净亏损2839.07万元—5145.81万元

Core Viewpoint - *ST Asia Pacific has released its annual performance forecast, indicating a significant fluctuation in revenue and net profit for 2025, primarily due to industry recovery and restructuring efforts [1] Group 1: Financial Performance - The expected total revenue for 2025 is projected to be between 417 million and 599 million yuan [1] - The net profit attributable to shareholders is forecasted to range from -51.4581 million to -28.3907 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses is estimated to be between -43.9538 million and -24.2504 million yuan [1] Group 2: Reasons for Performance Changes - The increase in revenue and net profit compared to the previous year is mainly attributed to the recovery of the industry cycle and the rebound in demand for pesticides and pharmaceutical intermediates [1] - The significant growth in shareholders' equity compared to the previous year is primarily due to the completion of bankruptcy reorganization, receipt of reorganization investment funds, debt exemptions, and cash donations [1]